Add Company
Join Now

Qlaris Bio Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Qlaris Bio's estimated annual revenue is currently $1.7M per year.(i)
  • Qlaris Bio's estimated revenue per employee is $155,000

Employee Data

  • Qlaris Bio has 11 Employees.(i)
  • Qlaris Bio grew their employee count by 0% last year.

Qlaris Bio's People

NameTitleEmail/Phone
1
Co-Founder and Chief Medical Officer Reveal Email/Phone
2
CEO & Co-FounderReveal Email/Phone
3
Executive Director Clinical OperationsReveal Email/Phone
4
Executive AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Qlaris Bio?

At Qlaris, our lead program is QLS-101, a novel topical ocular therapy that lowers intraocular pressure with a unique mechanism of action. QLS-101 is distinct from currently available therapies by lowering episcleral venous pressure (EVP) and improving outflow distal to the trabecular meshwork. This novel mechanism may enable the treatment of diseases where options remain limited, such as Normal Tension Glaucoma or Sturge-Weber Syndrome, and also provide an additive therapeutic option for patients requiring further efficacy for Primary Open Angle Glaucoma or in combination with Minimally-Invasive Glaucoma Surgery devices.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M12N/AN/A
#2
$3.5M12-14%N/A
#3
$2.2M15-46%N/A
#4
$2.6M167%N/A
#5
$1.7M20-29%N/A